Franklin Genomic Advancements ETF
Franklin Genomic Advancements ETF (HELX) Historical Volatility
HELX's 30 day historical volatility is 36.29%, in the 97th percentile of readings over the past year. This is a high percentile, meaning Franklin Genomic Advancements ETF shares have swung far more than usual. HELX's 30 day implied volatility sits at 27.73%, with an IV Rank of 23.02%, leaving IV 8.56 points below historical volatility. This means options are pricing in less movement than the stock has actually delivered, as of Nov 17, 2026.
Read more
Tracking HELX historical volatility helps you see how much Franklin Genomic Advancements ETF's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, HELX's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor HELX 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. HELX's 30 day historical volatility, or HELX HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing HELX's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.
Historical Volatility
Historical movement is elevated versus the past year. The stock has been unusually active.
As of Nov 17, 2026
As of Nov 17, 2026
As of Nov 17, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →